WO1997016076A1 - Feed enzyme preparations - Google Patents
Feed enzyme preparations Download PDFInfo
- Publication number
- WO1997016076A1 WO1997016076A1 PCT/DK1996/000455 DK9600455W WO9716076A1 WO 1997016076 A1 WO1997016076 A1 WO 1997016076A1 DK 9600455 W DK9600455 W DK 9600455W WO 9716076 A1 WO9716076 A1 WO 9716076A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enzyme
- feed
- preparation according
- water
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
Definitions
- the present invention relates to particulate, enzyme-containing preparations [such as a preparation in granulated form (in the following often simply referred to as a "granulate”)] which, when the enzyme (s) in question is/are relevant as an ingredient or ingredients of animal fodder, are particularly well suited for incorporation in animal feed compositions, especially animal feed compositions which are formulated as pellets ("pelletized”) or the like.
- pelletized animal feed compositions which are formulated as pellets
- the invention makes possible the manufacture of compositions with a very high degree of retention of enzymatic activity.
- animal feed (fodder) compositions can have a significant beneficial effect with respect to improvement of nutrient or mineral uptake from the fodder by the animal in question.
- formulation of animal feed compositions in the form of pellets is preferred for a variety of reasons, including: ease of handling and dosing; low levels of dust formation during handling; and ease of digestibility by the animal.
- pelletizing process itself facilitates heat-treatment of the feed for the purpose, for example, of eradicating pathogenic microorganisms, such as Salmonella sp., Listeria sp., Campylobacter sp. and the like; thus, for example, in order to effectively eradicate Salmonella sp. the feed must be heat-treated at a temperature of at least about 81°C during the pelletizing process.
- This heat treatment is very suitably accomplished by means of, e.g., steam treatment of the feed during the pelletizing process.
- EP 0 569 468 Bl which discloses (see Example 1 therein) that a coated form of a granulated enzyme preparation designated therein as "Bio-Feed Plus T” [the latter being a granulate of the so-called “T-granulate” type, i.e. a granulate produced in accordance with US 4,106,991 and which in addition to enzyme (s)
- BADORIGINAL i comprises, inter alia , 2-40% w/w of finely divided cellulose fibers] retained 90-100% of its original fungal ⁇ -glucanase activity when incorporated as an ingredient in a fodder composition subjected to a pelletizing procedure lasting 25-30 seconds and involving a temperature of 70°C and direct steam injection.
- uncoated T-granulate as well as a coated, "Bio-Feed Plus” granulate which was not of the T- granulate type both exhibited lower ( ⁇ ) retention of fungal ⁇ - glucanase activity.
- enzyme-containing granulates of the coated T-granulate type can display widely differing stability (notably thermal stability, e.g. stability during pelletizing processes) , depending on the nature and amounts of the non-enzyme constituents of the granulate, and the same applies in the case of enzyme-containing granulates of types other than the coated T-granulate type.
- An object of the investigations underlying the present invention was therefore to achieve increased stability of enzyme preparations in particulate form, e.g. enzyme-containing granulates, under conditions of heat and moisture such as those briefly outlined above - obtaining in processes (e.g. pelletizing processes) employed in the animal feed manufacturing industry.
- the present inventors have surprisingly found that significantly enhanced retention of enzymatic activity of particulate, enzyme- containing preparations (e.g. granulates) under pelletizing conditions as mentioned above can be achieved by inclusion in the particulate, enzyme-containing formulation of appropriate proportions of (i) a hydrophobic material, particularly when some or all of the hydrophobic material (which may, by way of example, be a waxy material, or a fatty material such as tallow) is present in a coating layer encapsulating an enzyme-containing core of the particles, and (ii) water-insoluble material (including the hydrophobic material mentioned above) .
- a hydrophobic material particularly when some or all of the hydrophobic material (which may, by way of example, be a waxy material, or a fatty material such as tallow) is present in a coating layer encapsulating an enzyme-containing core of the particles, and (ii) water-insoluble material (including the hydrophobic material mentioned above) .
- a first aspect of the present invention relates to a particulate, enzyme-containing preparation (e.g. a granulate) comprising: a total of at least 1% by weight (w/w) of one or more hydrophobic substances,- and a total of at least 75% w/w of one or more water-insoluble substances, including the hydrophobic substance (s) .
- the hydrophobic substance (s) constitute at least 5% w/w of the enzyme-containing preparation, more preferably often at least about 8% w/w.
- the water-insoluble substance (s) preferably constitute at least 80% w/w, more preferably at least 85% w/w, for example at least 90% w/w of the enzyme-containing preparation.
- the weight percentages referred to are based on the total weight of the finished preparation (i.e. including, e.g., any coating layer which may be present) .
- the hydrophobic substance (s) is/are distributed substantially evenly throughout the material of the particles of the preparation (or at least throughout the material of typical particles taken from the preparation) .
- the content of hydrophobic substance (s) in such preparations may suitably be in the range of 5-95% w/w. In certain cases, a content of hydrophobic substance (s) as high as about 98% w/w may even be appropriate for a particulate, enzyme-containing preparation of this type.
- preferred particulate, enzyme-containing preparations of the invention comprise (a) an enzyme-containing core and (b) a coating layer which contains the hydrophobic substance (s) and which surrounds or encapsulates the enzyme-containing core.
- the hydrophobic substance (s) will suitably constitute from 1 to 50% w/w of the preparation, often from 5 to 25% w/w, and more typically from 5 to 15% w/w thereof.
- particle as employed in the context of enzyme- containing preparations according to the present invention is intended to embrace particles of any shape or form, such as particles having some essentially regular (e.g. spherical) geometry, particles of irregular shape, or particles in the form of regular or irregular flakes, as well as mixtures of particles having different shapes or forms (such as mixtures of the latter-mentioned types of particles) .
- Enzyme classification numbers (EC numbers) referred to in the present specification with claims are in accordance with the Recommendations (1992) of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology, Academic Press Inc., 1992.
- the enzyme (s) in a particulate, enzyme-containing preparation according to the invention may be any type of enzyme, in particular any type of enzyme of relevance in the context of animal feed compositions.
- the enzyme (s) may be chosen among phytases [in particular 3-phytases (i.e. myo- inositol-hexakisphosphate 3-phosphohydrolases; classified under EC 3.1.3.8) or 6-phytases (i.e. yo-inositol-hexakisphosphate 6-phosphohydrolases; classified under EC 3.1.3.26)] , phosphatases (e.g. enzymes classified under EC 3.1.3.1 or EC 3.1.3.2), xylanases (e.g.
- ⁇ -glucanases e.g. enzymes classified under EC 3.2.1.75, EC 3.2.1.71, EC 3.2.1.59 or EC 3.2.1.39
- ⁇ - galactanases e.g. enzymes classified under EC 3.2.1.89 (endo- 1,4- ⁇ -galactanases) or EC 3.2.1.90 (endo-1 , 3- ⁇ -galactanases)
- ⁇ -galactosidases e.g. enzymes classified under EC 3.2.1.22
- ⁇ -galactosidases e.g.
- enzymes classified under EC 3.2.1.23 (“lactases") ] , ⁇ -amylases (EC 3.2.1.1) , ⁇ -amylases (EC 3.2.1.2) , cellulases (e.g. enzymes classified under EC 3.2.1.4) , pectinases (e.g. enzymes classified under EC 3.2.1.15) and peptidases (EC 3.4) , including "proteinases” or "proteases", such as enzymes classified under EC 3.4.2: .
- one or more different enzymes may be incorporated in a particula , enzyme-containing preparation according to the invention. Tne manner in which the enzyme content of the particles of an enzyme-containing preparation of the invention is distributed within the particles appears to be unimportant. The enzyme content may be thus be distributed evenly or unevenly throughout the material of a given particle.
- the enzyme content of the particles may be substantially confined to the core of the particles, or it is recognized that at least some of the enzyme content may be present in the coating layer (s) .
- the content of enzyme protein in a particulate, enzyme- containing preparation of the invention will generally be in the range of 0.01-10% by weight, such as 0.1-10% by weight (w/w) , of the preparation, more typically 0.2-5% w/w, often 0.3-2.5% w/w.
- the enzyme content will depend to a large extent of the nature of the enzyme (s) present in the particulate preparation.
- the particulate preparation may also contain other material originating from the enzyme production process, in that it is preferred practice in the industry to employ enzyme preparations which are not completely purified for incorporation in particulate preparations in general.
- the particulate, enzyme-containing preparation of the invention may, as already indicated to some extent ⁇ vide supra) , very suitably be a granulate (i.e. in granulated form) , such as a "T- granulate" ( vide supra) or some other type of granulate.
- the particles of a particulate, enzyme-containing preparation of the invention may, for example, be particles comprising a suitable proportion of a meltable component - such as palm oil (and/or another meltable vegetable oil or fat) , hydrogenated palm oil (and/or another hydrogenated vegetable oil) , tallow, hydrogenated tallow or a wax - which functions as a matrix for the enzyme (s) and other ingredients.
- a meltable component such as palm oil (and/or another meltable vegetable oil or fat)
- hydrogenated palm oil and/or another hydrogenated vegetable oil
- tallow hydrogenated tallow
- a wax - which functions as a matrix for the enzyme (s) and other ingredients.
- a practical upper limit for the particle size of the majority of particles in a preparation to be incorporated in a feed composition will normally be about 2 mm.
- the size of a particle may be regarded as the greatest linear dimension of the particle; thus, in the case of, e.g., a substantially spherical particle (such as a substantially spherical granulate particle) , the particle size in question will be the diameter of the particle.
- the lower limit to the size of particles of an enzyme-containing preparation of the invention will normally be set primarily by the desirability of avoiding dust formation during production and handling of the preparation.
- a practical lower limit for the size of such particles will often be about 0.1 mm.
- hydrophobic substance designates a substance which is not readily wetted by water, i.e. which tends to repel water.
- Such substances - examples of which are oils, fats, hydrocarbon waxes and numerous types of resins - are in general essentially completely insoluble in water.
- Hydrophobic substances which are of particular relevance in the context of the present invention are normally substances which are soluble in organic solvents of the hydrocarbon type (e.g. hexane, heptane and the like) or chlorinated hydrocarbon type
- Suitable examples hereof include various glyceride lipids (i.e. mono-, di- or triglycerides) , such as animal tallow (e.g. beef or mutton tallow) and vegetable oils, and certain derivatives thereof.
- hydrophobic substances are those which are solid at ambient temperature and which have a melting point of about 40°C or above.
- examples hereof include substances such as certain native or hardened (hydrogenated) vegetable oils or fats, e.g. hydrogenated palm oil, hydrogenated palm kernel oil or hydrogenated soya bean oil, as well as materials such as hydrogenated tallow (e.g. hydrogenated beef tallow or mutton tallow) .
- water-insoluble substance as employed in the context of the present invention embraces substances ranging from those which are essentially completely insoluble in water to those which exhibit a very low degree of solubility in water (such as a solubility of, say, at most about 1 gram per 100 ml of pure water) .
- water-insoluble substances in the context of the invention include, but are not limited to, hydrophobic substances as defined above.
- Other types of water-insoluble substances of relevance in the context of the invention include various inorganic salts (e.g. calcium carbonate, calcium sulfate, calcium hydrogen phosphate or magnesium carbonate) , mineral materials comprising aluminium silicates (e.g. clays, such as kaolin, bentonite or fuller's earth) , inert metal oxides
- various macromolecular substances e.g. polysaccharides, such as cellulose or certain types of starch, as well as milled cereals or cereal flour (e.g. produced from cereals such as wheat, barley or rye) , or soya (e.g. soya meal or soya flour)] and activated carbon.
- polysaccharides such as cellulose or certain types of starch
- cereal flour e.g. produced from cereals such as wheat, barley or rye
- soya e.g. soya meal or soya flour
- the present invention further relates to a process for the production of an enzyme-containing animal feed composition, wherein an enzyme-containing preparation according to the invention, in admixture with other constituents of the final feed composition, is subjected to a steam-heating step (such as is often involved in pelletizing procedures as outlined above, in which the final feed composition is pelletized) .
- a further aspect of the invention relates to the use of a particulate, enzyme-containing preparation according to the invention in the manufacture of an enzyme-containing animal feed composition.
- an enzyme-containing animal feed composition obtained or obtainable by a production process (outlined above) according to the invention.
- enzyme-containing, particulate preparations formulated in accordance witr. the invention may also be employed in the production of otne: (non-feed) enzyme- containing compositions whose manufacture entails a heat- treatment as outlined herein.
- the principles of the present invention are applicable not only to improving the retention of enzyme activity in connection with heat-treatment (e.g. steam- treatment) of enzyme-containing preparations, but may be employed analogously to achieve, for example, improved stability of vitamins, co-vitamins, amino acids, medicaments (e.g. antibiotics or growth-regulating substances) , mineral additives and the like, or enhanced viability of microorganisms (e.g. bacteria or fungi) , following heat-treatment (e.g. steam- treatment) of particulate preparations incorporating these.
- heat-treatment e.g. steam- treatment
- finely ground “filler” (which in the case of preparations according to the invention comprises one or more water-insoluble substances within the context of the invention)
- Granulation was carried out in a L ⁇ dige mixer, equipped with the necessary mixing paddle and rotating knives.
- the granulate was then transferred to a fluid-bed dryer for drying, and the dried granulate was then cooled and sieved.
- Coating of the resulting T-granulate particles with a coating comprising hydrophobic substance (s) was also carried out in a L ⁇ dige mixer:
- the dry granulate particles were heated to a temperature in the range of about 70-85°C, usually 75-85°C (depending on the melting characteristics of the hydrophobic component employed) .
- the hydrophobic component was melted and sprayed evenly onto the granulate particles in the mixer.
- a second filler was incorporated in the manner described in EP 0 569 468 Bl . After application of the hydrophobic component and filler, the resulting T-granulate was cooled to ambient temperature and sieved to remove very fine particles and undesirably large particles .
- T-granulates employed in the working examples given hereafter had a predominant particle size (diameter) in the range of 0.3-1.2 mm.
- the percentage total content of water-insoluble substances is then calculated as: 100 - [ (S x 50) /W] .
- Phytase-containing, granulate preparations Five different phytase-containing granulates were prepared by the T- granulation procedure ( vide supra) .
- the phytase solution used in the granulations was from the same source as that used in the production of the product Phytase Novo L (see Novo Nordisk Product Sheet B-722a, available on request from Novo Nordisk A/S, Bagsvaerd, Denmark) .
- Phytase Novo L is a liquid enzyme formulation with a standardised phytase activity.
- the five granulates designated PA, PB, PC, PD and PE, respectively, were prepared using the following constituents in the amounts specified (given on a dry matter basis) :
- the main filler employed in granulate PA was the water-soluble salt sodium chloride, and the total contents of hydrophobic substance (hydrogenated beef tallow) and water-insoluble substances (hydrogenated beef tallow + kaolin + cellulose + calcium carbonate > were 9% w/w and 39% w/w, respectively.
- hydrophobic substance hydrogenated beef tallow
- water-insoluble substances hydrogenated beef tallow + kaolin + cellulose + calcium carbonate > were 9% w/w and 39% w/w, respectively.
- the latter values agree well with the values
- the main filler employed in granulate PB was the water-insoluble salt calcium carbonate, and the total content of water-insoluble substances was 84% w/w. This value is in excellent agreement with the value (84% w/w) determined employing the assay procedure ⁇ de ⁇ cribed above for water-insoluble substances. No hydrophobic substance (as defined herein) was employed, which is consistent with the finding of ⁇ 1% w/w of hydrophobic substance using the above-described assay for hydrophobic substances.
- the phytase activity of granulate PB was determined as 1760 FYT/g, using Novo Nordisk analytical method KAL-SM-0403.01/01 ( vide supra)
- the main filler employed in granulate PC was the water-insoluble salt calcium carbonate, and the total contents of hydrophobic substance (hydrogenated beef tallow) and water-insoluble substances (hydrogenated beef tallow + kaolin + cellulose + calcium carbonate) were 11% w/w and 87% w/w, respectively.
- the latter values agree well with the values (10% w/w and 87%, respectively) determined employing the assay procedures described above.
- the phytase activity of granulate PC was determined as 950 FYT/g, using Novo Nordisk analytical method KAL-SM-0403.01/01 ( vide supra) .
- the main filler employed in granulate PD was the water-insoluble salt calcium hydrogen phosphate (CaHPO , and the total contents of hydrophobic substance (hydrogenated palm oil) and water-insoluble substances (hydrogenated palm oil + kaolin + cellulose + calcium carbonate + calcium hydrogen phosphate) were 5.5% w/w and 79.8% w/w, respectively.
- the phytase activity of granulate PD was determined as 1430 FYT/g, using Novo Nordisk analytical method KAL-SM-0403.01/01 ( vide supra) .
- the main filler employed in granulate PE was the water-soluble salt sodium sulfate, and the total contents of hydrophobic substance (hydrogenated palm oil) and water-insoluble substances (hydrogenated palm oil + kaolin + cellulose + calcium carbonate) were 8.5% w/w and 40.1% w/w, respectively.
- the phytase activity cf granulate PE was determined as 2400 FYT/g, using Novo Nordisk analytical method KAL-SM-0403.01/01 ( vide supra) .
- xylanase-containing, granulate preparations Five different xylanase-containing granulates were prepared by the T- granulation procedure ( vide supra) .
- the xylanase solution used in the granulations was from the same source as that used in the production of the product Bio-FeedTM Wheat L (see, e.g., Novo Nordisk publication B-854a, available on request from Novo Nordisk A/S, Bagsvaerd, Denmark) .
- Bio-FeedTM Wheat L is a liquid enzyme formulation with a standardised xylanase activity.
- the five granulates designated XA, XB, XC, XD and XE, respectively, were prepared using the following constituents in
- the main filler employed in granulate XA was the water-soluble salt sodium sulfate, and the total contents of hydrophobic substance (hydrogenated beef tallow) and water-insoluble substances (hydrogenated beef tallow + cellulose + calcium carbonate) were 8% w/w and 36% w/w, respectively. The latter values agree well with the values (9% w/w and 36%, respectively) determined employing the assay procedures described above.
- the xylanase activity of granulate XA was determined as 810 FXU/g, using Novo Nordisk analytical method KAL-SM-0356.01/01 (available on request from Novo Nordisk A/S, Bagsvaerd, Denmark) .
- the latter values are in excellent agreement with the values (8% w/w and 90%, respectively) determined employing the assay procedures described above.
- the main filler employed in granulate XC was the water-soluble salt sodium sulfate, and the total content of water-insoluble substances was 17% w/w.
- the value determined employing the assay procedure described above for water-insoluble substances was 23% w/w.
- No hydrophobic substance (as defined herein) was employed, which is consistent with the finding of ⁇ 1% w/w of hydrophobic substance using the above-described assay for hydrophobic substances.
- the xylanase activity of granulate XC was determined as 1080 FXU/g, using Novo Nordisk analytical method KAL-SM-0356.01/01 ( vide supra) .
- t -. mam filler employed in granulate XD was the water-insolub - salt calcium sulfate, and the total content of water-in ⁇ oluble sucstances was 87% w/w. This agrees well with the value (88% w/w determined employing the assay procedure described above for water-insoluble substances. No hydrophobic sub ⁇ tance (as defmed herein) wa ⁇ employed, which is consistent with the finding of ⁇ 1% w/w of hydrophobic substance using the above-described assay for hydrophobic substances.
- the xylanase activity of granulate XD was determined as 1090 FXU/g, using Novo Nordisk analytical method KAL-SM-0356.01/01 (vide supra) .
- the main filler employed in granulate XE was the water-insoluble salt calcium carbonate, and the total contents of hydrophobic sub ⁇ tance (hydrogenated beef tallow) and water-insoluble substances (hydrogenated beef tallow + cellulose + calcium carbonate) were 8% w/w and 88% w/w, respectively.
- the latter values agree quite well with the values (6% w/w and 90% w/w, respectively) determined employing the assay procedures described above.
- the xylanase activity of granulate XE was determined as 410 FXU/g, using Novo Nordisk analytical method KAL-SM-0356.01/01 ( vide supra) .
- a mash feed formulation of the following composition (w/w) was chosen: 62% wheat
- the preparation m question was mixed thoroughly into a portion of the above feed formulation.
- the mixing ratio was such as to give a phytase activity in the final feed formulation in the range of about 1500-2500 FYT/kg
- the mixing ratio was such as to give a phytase activity in the final feed formulation in the range of about 3000-4000 FYT/kg.
- the phytase activity of a sample of each of the five resulting phytase-enriched feed formulations was determined using Novo Nordisk analytical method ED-9513614, described below.
- the endogenous phyta ⁇ e activity of a sample of the above-described feed formulation to which no phytase- containing preparation had been added was determined in the same manner, and the value herefor was subtracted from the value for each phytase-enriched feed formulation.
- Scope The assay is suited for determination of the phytase activity of animal feeds containing >50 FTU/kg.
- Diluted nitric Acid Dilute 1 volu ⁇ - tf nitric acid (65%) with 2 volumes of water. Store at roc- temperature. Maximum storage time: indefinite.
- Ammonium heptamolybdate reagent out 100.0 g of (NH 6 Mo 7 0 24 .4H 2 0. Dissolve in approximatel 8C0 ml of water. Add 10 ml of 25% ammonia solution. Add water to final volume 1000 ml. Store at room temperature in the dark. Maximum storage time: 8 weeks.
- Ammonium vanadate reagent Weigh 2.35 g NH 4 V0 3 . Dissolve completely in 400 ml of water, preheated to 50-60°C. Then add 20 ml of diluted nitric acid (see 5.1, above Add water to final volume 1000 ml. Store at room temperature the dark. Maximum storage time: 8 weeks.
- MoV stop reagent Add 1 volume of ammonium vanadate reagent (see 5.3, above) to 1 volume of ammonium molybdate reagent (see 5.2, above) . Then add 2 volumes of diluted nitric acid (see 5.1, above) . Mix. Store at room temperature. Prepare fresh each day.
- Phytate substrate solution Weigh out 1.40 g of sodium phytate. Dissolve in 200 ml of acetate buffer (see 5.5, above) .
- Phosphate stock standard ⁇ olution 50 mM: Dry about 10 g of KH 2 P0 4 in a vacuum oven at 105°C for 2 hours. Store in a dessicator. Weigh accurately 682 mg dried KH 2 P0 4 . Dissolve in 100 ml acetate buffer (see 5.5, above) . Store at 0-5°C. Maximum storage time: 1 week.
- Feed Sample Grind a repre ⁇ entative ⁇ ample of the feed to a powder, for example u ⁇ ing a hou ⁇ ehold coffee grinder.
- Feed Extraction Weigh out 40.0 ⁇ 0.25 g of the feed powder. Add 500 ml of deionised water containing 16 ml 10% cal- cium chloride ⁇ olution (see 5.6, above) . Stir vigorously for 60 minutes. Transfer approximately 5 ml into glass centrifuge tubes. Centrifuge, e.g. for 5 minutes at 3000 rpm. Prepare a series of glass test tubes. 4 tubes are needed for each feed sample (note that these tubes will be centrifuged after the en- zyme reaction stage - their size and quality should be chosen accordingly) . Pipette 100 ⁇ l of the centrifuged feed sample into each of the 4 tubes. 7.2.
- Enzyme sample ⁇ , phosphate standard and buffer 15 second intervals.
- Example: 40.2 g of feed extracted in 500 ml water plus 16 ml CaCl 2 solution. Feed concentration 0.0779 g/ml or 0.00779 g/100 ⁇ l.
- Vanadate toxicity Vanadate (Vanadium in oxidation state +5) is highly toxic (LD 50 p.o. in rats 18 mg/kg) .
- the MoV stop reagent contains 0.6 mg/ml vanadate.
- the final assay solutions (which require the most handling, including centrifugation) contain 0.24 mg/ml vanadate (and ca. 2% HN0 3 ) .
- Calcium addition is included in the above method for feed samples. Calcium addition decreases the production of free phosphate during the sample preparation step ⁇ , i.e. decreases both blank and enzyme OD values.
- the phosphate standard is linear up to 0D 415 of at least 1.5.
- the phosphate standard measurement is extremely reproducible, and use of only one phosphate concentra ⁇ tion gives a sufficiently precise calibration ⁇ 0D 415 for the lOmM phosphate standard is close to 0.37.
- each phytase-enriched feed formulation was then subjected to a steam-heat g procedure in which the conditions of the steam-heating procedure as used in a typical feed pelletizing process are simulated: 100 g of the feed formulation in question was transferred to a Buchner funnel (Schott Duran 21 341 44 05) and heated by passing steam up through the funnel and thus through the feed formulation contained in the funnel. Steam-heating was continued for 30 seconds, during which time the feed was stirred evenly. The supply of steam was kept constant throughout all runs and was sufficient to bring the temperature of the feed formulation up to >85°C at the end of the 30 second heating period. The heated feed formulation was then poured out of the funnel and cooled to ambient temperature.
- a steam-heat g procedure in which the conditions of the steam-heating procedure as used in a typical feed pelletizing process are simulated: 100 g of the feed formulation in question was transferred to a Buchner funnel (Schott Duran 21 341 44 05) and heated by passing steam up through the funnel
- the phytase activity of a sample of each of the steam-heated feed formulations was determined using Novo Nordisk analytical method ED-9513614 ( vide supra) , and the activity of each of the steam-heated, phytase-enriched preparations wa ⁇ corrected by
- the xylanase activity of a sample of each of the five resulting xylanase-enriched feed formulations was determined u ⁇ ing Novo Nordi ⁇ k analytical method ED-9511460.2, de ⁇ cribed below.
- the xylanase is extracted from the feed sample into an aqueous solution.
- the enzyme i ⁇ then allowed to react with a modified wheat xylan. This wheat xylan has been cross-linked
- the assay is well suited for determination of the Bio- FeedTM Wheat L xylanase activity of feeds that contain 50-250 FXU/kg. Higher activities can also be assayed, providing that the concentrations and dilutions are adjusted. Guidelines for the activity range 200-1000 FXU per kg are included herein.
- Volumetric equipment A range of repeating pipettes, dispensers and volumetric glassware is required. The equipment used should deliver the specified volumes to within ⁇ 1%.
- Tris (hydroxymethyl)methane e.g. Sigma 7-9, Sigma T-1378
- Bio-FeedTM Wheat L (xylanase preparation with known activity) , Novo Nordisk A/S , Denmark .
- Phosphate buffer, pH 6 Dissolve 60.0 g of NaH 2 P0 4 .H 2 0 and 11.6g of Na 2 HP0 4 .2H 2 0 in approximately 4500 ml of water. Adjust pH with IN HCl or IN NaOH to 6.00 ⁇ 0.05. Dilute to final volume 5000 ml. Store at room temperature. Maximum storage time: 1 week.
- Tris stop reagent Dissolve 10.0 g of tris (hydroxymethyl) - methane in 1000 ml of water. Store at room temperature. Maximum storage time: 1 week.
- Enzyme standard solution From the Bio-FeedTM Wheat L (with known xylanase activity) prepare a solution in buffer with accurately known activity in the range 4.8-5.2 FXU/ml. For exam ⁇ ple, if the Bio-FeedTM Wheat L product has 500 FXU/g, weigh out accurately about 1000 mg and dissolve in 100 ml of phosphate buffer (see 5.1, above) . Store at room temperature. Maximum storage time: 2 hours.
- Feed Sample The "feed sample” is the entire sample of feed that is received by the laboratory.
- FX is a 100 g sample, taken from the "feed sample”. The procedure that is used to take out FX must ensure that it is a representative sample.
- FX is ground to a powder which is then used in the assay. For repeat assays on the same "feed sample” the entire sampling procedure should be repeated.
- Tube ⁇ 1-3 assay, sample "aS”.
- Tubes 4 blank
- Tubes 5-7 assay, sample "aE"
- Tubes 8 blank
- Tubes 9-11 assay, sample "bS" Tubes 12 : blank
- Tubes 13-15 assay, sample "bE"
- the tubes are treated as follows: The tubes are taken up, 5 ml Tris ⁇ top reagent (see 5.2, above) is added, the cap is replaced and the contents are mixed well with a vortex mixer. Allow all tubes to stand at room temperature for 15 minutes, then mix again and filter through a Whatman GF/C filter into a clean tube. Measure OD at 585 nm for all 16 samples. Complete these measurements within 30 minutes after the filtration. 8 . Calculation :
- the xylanase activity of the "feed sample” is given as the mean of the "a” and "b" values.
- the formulations were pelletized using a pilot scale steam conditioner (continuous horizontal mixer equipped with paddle blades and steam inlets) .
- the flow rate through the conditioner was 200 kg/hour
- the residence time in the conditioner was 30 seconds
- the steam input was adjusted to give a temperature in the outlet feed stream of 95°C.
- the feed entered a Simon Heesen extruder and was pressed through a matrix with hole size 3mm x 35mm to form pellets.
- a sample of pellets was transferred to a cooler and was cooled to ambient temperature in a stream of air.
- a sample of the cooled pellets was taken for xylana ⁇ e activity analy ⁇ i ⁇ .
- the xylana ⁇ e activity of a sample of each of the steam-heated feed formulations was determined using Novo Nordisk analytical method ED 9511460.2 ( vide supra) .
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Fodder In General (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9516999A JPH11514240A (en) | 1995-11-02 | 1996-11-01 | Feed enzyme preparation |
EP96937191A EP0858266A1 (en) | 1995-11-02 | 1996-11-01 | Feed enzyme preparations |
AU74898/96A AU7489896A (en) | 1995-11-02 | 1996-11-01 | Feed enzyme preparations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK122795 | 1995-11-02 | ||
DK1227/95 | 1995-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997016076A1 true WO1997016076A1 (en) | 1997-05-09 |
Family
ID=8102426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1996/000455 WO1997016076A1 (en) | 1995-11-02 | 1996-11-01 | Feed enzyme preparations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0858266A1 (en) |
JP (1) | JPH11514240A (en) |
CN (1) | CN1201372A (en) |
AU (1) | AU7489896A (en) |
WO (1) | WO1997016076A1 (en) |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997042837A1 (en) * | 1996-05-13 | 1997-11-20 | Hoechst Aktiengesellschaft | Enzyme pre-granules for granular fodder |
US6190591B1 (en) | 1996-10-28 | 2001-02-20 | General Mills, Inc. | Embedding and encapsulation of controlled release particles |
US6436453B1 (en) | 2000-06-16 | 2002-08-20 | General Mills, Inc. | Production of oil encapsulated minerals and vitamins in a glassy matrix |
US6468568B1 (en) | 2000-06-16 | 2002-10-22 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
US6500463B1 (en) | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
US6500426B1 (en) | 1997-06-04 | 2002-12-31 | Rudolf Carolus Maria Barendse | Carbohydrate-based enzyme-containing granules for use in animal feed |
US6511699B1 (en) | 1999-03-31 | 2003-01-28 | Cornell Research Foundation, Inc. | Enzymes with improved phytase activity |
WO2003059087A1 (en) * | 2002-01-15 | 2003-07-24 | Basf Ag | Granulates containing feed-enzymes |
WO2003059086A1 (en) * | 2002-01-15 | 2003-07-24 | Basf Ag | Granulates containing feed-enzymes |
WO2006034710A1 (en) * | 2004-09-27 | 2006-04-06 | Novozymes A/S | Enzyme granules |
US7026150B2 (en) | 1998-06-25 | 2006-04-11 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
US7186533B2 (en) | 1999-02-10 | 2007-03-06 | Basf Aktiengesellschaft | Granulates containing feed-enzymes |
US7556802B1 (en) | 1999-06-25 | 2009-07-07 | Basf Se | Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof |
US7736680B2 (en) | 2002-09-13 | 2010-06-15 | Cornell Research Foundation, Inc. | Using mutations to improve Aspergillus phytases |
US7803414B2 (en) | 2005-10-31 | 2010-09-28 | General Mills Ip Holdings Ii, Llc | Encapsulation of readily oxidizable components |
US7833743B2 (en) | 2001-10-31 | 2010-11-16 | Phytex, Llc | Phytase-containing animal food and method |
US7919297B2 (en) | 2006-02-21 | 2011-04-05 | Cornell Research Foundation, Inc. | Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase |
US20120093976A1 (en) * | 2004-09-27 | 2012-04-19 | Novozymes A/S | Enzyme Granules |
WO2012110776A2 (en) | 2011-02-18 | 2012-08-23 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2012110777A2 (en) | 2011-02-18 | 2012-08-23 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2012110778A2 (en) | 2011-02-18 | 2012-08-23 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US8313757B2 (en) | 1998-03-23 | 2012-11-20 | General Mills, Inc. | Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
EP2537918A1 (en) | 2011-06-20 | 2012-12-26 | The Procter & Gamble Company | Consumer products with lipase comprising coated particles |
WO2012175401A2 (en) | 2011-06-20 | 2012-12-27 | Novozymes A/S | Particulate composition |
EP2497376A3 (en) * | 2005-10-12 | 2013-01-02 | Danisco US Inc. | Stable, durable granules with active agents |
US8540984B2 (en) | 2006-08-03 | 2013-09-24 | Cornell Research Foundation, Inc. | Phytases with improved thermal stability |
WO2014020138A2 (en) * | 2012-08-03 | 2014-02-06 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2014191170A1 (en) | 2013-05-30 | 2014-12-04 | Novozymes A/S | Particulate enzyme composition |
WO2015114112A1 (en) | 2014-01-31 | 2015-08-06 | Dupont Nutrition Biosciences Aps | Protein |
WO2015116395A1 (en) | 2014-01-31 | 2015-08-06 | Danisco Us Inc. | Methods for improving by-products from fermentation processes using xylanase |
EP1974030B1 (en) | 2006-01-17 | 2016-09-14 | AB Enzymes GmbH | Improved enzyme formulations for animal feed |
WO2017040499A1 (en) | 2015-09-02 | 2017-03-09 | Dupont Nutrition Biosciences Aps | Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal |
WO2018005225A1 (en) | 2016-06-30 | 2018-01-04 | Danisco Us Inc | Aspartic proteases |
WO2018057420A1 (en) | 2016-09-23 | 2018-03-29 | Dupont Nutrition Biosciences Aps | Use of low ph active alpha-1,4/1,6-glycoside hydrolases as a feed additive for ruminants to enhance starch digestion |
WO2018118815A1 (en) | 2016-12-21 | 2018-06-28 | Dupont Nutrition Biosciences Aps | Methods of using thermostable serine proteases |
WO2018164876A1 (en) | 2017-03-06 | 2018-09-13 | Dupont Nutrition Biosciences Aps | Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal |
WO2018169750A1 (en) | 2017-03-15 | 2018-09-20 | Danisco Us Inc | Trypsin-like serine proteases and uses thereof |
WO2018169784A1 (en) | 2017-03-15 | 2018-09-20 | Dupont Nutrition Biosciences Aps | Trypsin-like serine proteases and uses thereof cross-reference to related application |
AU2017202595B2 (en) * | 2005-10-12 | 2018-11-22 | Genencor International, Inc. | Stable, durable granules with active agents |
WO2019173424A1 (en) | 2018-03-09 | 2019-09-12 | Danisco Us Inc | Glucoamylases and methods of use thereof |
US10463701B2 (en) | 2013-12-31 | 2019-11-05 | DuPont Nutrition BioScience ApS | Blends of Bacillus strains and enzymes |
CN110846303A (en) * | 2019-11-23 | 2020-02-28 | 吉林省富生医疗器械有限公司 | Peroxidase protective agent |
WO2020106796A1 (en) | 2018-11-20 | 2020-05-28 | Dupont Nutrition Biosciences Aps | ENGINEERED ROBUST HIGH Tm-PHYTASE CLADE POLYPEPTIDES AND FRAGMENTS THEREOF |
WO2021007379A1 (en) | 2019-07-09 | 2021-01-14 | Dupont Nutrition Biosciences Aps | Fat coated particulate enzyme compositions |
WO2021034660A1 (en) | 2019-08-16 | 2021-02-25 | Dupont Nutrition Biosciences Aps | Compositions for gut health comprising combinations of lactobacillus strains |
WO2021046073A1 (en) | 2019-09-05 | 2021-03-11 | Dupont Nutrition Biosciences Aps | Feed composition |
WO2021080864A2 (en) | 2019-10-21 | 2021-04-29 | Dupont Nutrition Biosciences Aps | Compositions for gut health |
WO2021102238A1 (en) | 2019-11-20 | 2021-05-27 | Dupont Nutrition Biosciences Aps | Thermostable phytase variants |
WO2021127360A1 (en) | 2019-12-19 | 2021-06-24 | Dupont Nutrition Biosciences Aps | Diet formulations |
WO2021158927A1 (en) | 2020-02-07 | 2021-08-12 | Dupont Nutrition Biosciences Aps | Feed compositions for animal health |
WO2021173974A1 (en) | 2020-02-28 | 2021-09-02 | Dupont Nutrition Biosciences Aps | Feed compositions |
WO2021212095A1 (en) | 2020-04-17 | 2021-10-21 | Danisco Us Inc. | Glucoamylase and methods of use thereof |
WO2022081947A1 (en) | 2020-10-16 | 2022-04-21 | Dupont Nutrition Biosciences | Feed compositions for animal health |
WO2022169933A2 (en) | 2021-02-03 | 2022-08-11 | Dupont Nutrition Biosciences Aps | Compositions for gut health |
WO2023049488A1 (en) | 2021-09-27 | 2023-03-30 | Dupont Nutrition Biosciences Aps | Feed additive compositions and methods for using the same |
WO2023064905A1 (en) | 2021-10-15 | 2023-04-20 | Danisco Us Inc. | Glucoamylase variants and methods for use thereof |
WO2023122676A1 (en) | 2021-12-24 | 2023-06-29 | Danisco Us Inc. | Hybrid glucoamylases and methods of use thereof |
WO2023225510A1 (en) | 2022-05-17 | 2023-11-23 | Dupont Nutrition Biosciences Aps | Feed additive comprising enzyme combinations |
WO2024064653A1 (en) | 2022-09-20 | 2024-03-28 | Dupont Nutrition Biosciences Aps | Variant anti-viral polypeptides |
US11981942B2 (en) | 2013-07-23 | 2024-05-14 | International N&H Denmark Aps | Xylanases for solubilizing arabinoxylan-containing material |
WO2024124013A1 (en) | 2022-12-09 | 2024-06-13 | International N&H Denmark Aps | Feed formulations comprising a phytase for dairy ruminant animals |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101668518B (en) * | 2007-02-14 | 2014-05-07 | 尼尔·A·所罗门 | A lactase formulation |
CN101120730B (en) * | 2007-09-13 | 2010-07-28 | 武汉工业学院 | Paddy special-purpose compound enzyme feed additive |
KR101284539B1 (en) * | 2011-01-13 | 2013-07-11 | (주)진바이오텍 | Complex enzyme composition for degradating non starch polysaccharide and method for preparation thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992012645A1 (en) * | 1991-01-25 | 1992-08-06 | Novo Nordisk A/S | Use of an enzyme containing granulate and method for production of a pelletized fodder |
-
1996
- 1996-11-01 EP EP96937191A patent/EP0858266A1/en not_active Withdrawn
- 1996-11-01 AU AU74898/96A patent/AU7489896A/en not_active Abandoned
- 1996-11-01 CN CN96197980A patent/CN1201372A/en active Pending
- 1996-11-01 WO PCT/DK1996/000455 patent/WO1997016076A1/en not_active Application Discontinuation
- 1996-11-01 JP JP9516999A patent/JPH11514240A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992012645A1 (en) * | 1991-01-25 | 1992-08-06 | Novo Nordisk A/S | Use of an enzyme containing granulate and method for production of a pelletized fodder |
Cited By (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221406B1 (en) | 1996-05-13 | 2001-04-24 | Beate Meschonat | Enzyme pre-granules for granular fodder |
WO1997042837A1 (en) * | 1996-05-13 | 1997-11-20 | Hoechst Aktiengesellschaft | Enzyme pre-granules for granular fodder |
US6190591B1 (en) | 1996-10-28 | 2001-02-20 | General Mills, Inc. | Embedding and encapsulation of controlled release particles |
US7611701B2 (en) | 1997-06-04 | 2009-11-03 | Basf Aktiengesellschaft | Preparation of phytase-containing granulates for use in animal feed |
US6500426B1 (en) | 1997-06-04 | 2002-12-31 | Rudolf Carolus Maria Barendse | Carbohydrate-based enzyme-containing granules for use in animal feed |
US8313757B2 (en) | 1998-03-23 | 2012-11-20 | General Mills, Inc. | Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
US7026150B2 (en) | 1998-06-25 | 2006-04-11 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
US8993300B2 (en) | 1998-06-25 | 2015-03-31 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
US7186533B2 (en) | 1999-02-10 | 2007-03-06 | Basf Aktiengesellschaft | Granulates containing feed-enzymes |
US6511699B1 (en) | 1999-03-31 | 2003-01-28 | Cornell Research Foundation, Inc. | Enzymes with improved phytase activity |
US6974690B2 (en) | 1999-03-31 | 2005-12-13 | Cornell Research Foundation, Inc. | Phosphatases with improved phytase activity |
US7556802B1 (en) | 1999-06-25 | 2009-07-07 | Basf Se | Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof |
US6500463B1 (en) | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
US6468568B1 (en) | 2000-06-16 | 2002-10-22 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
US6436453B1 (en) | 2000-06-16 | 2002-08-20 | General Mills, Inc. | Production of oil encapsulated minerals and vitamins in a glassy matrix |
US7833743B2 (en) | 2001-10-31 | 2010-11-16 | Phytex, Llc | Phytase-containing animal food and method |
WO2003059086A1 (en) * | 2002-01-15 | 2003-07-24 | Basf Ag | Granulates containing feed-enzymes |
CN100345494C (en) * | 2002-01-15 | 2007-10-31 | 巴斯福股份公司 | Granulates containing feed-enzymes |
CN100345495C (en) * | 2002-01-15 | 2007-10-31 | 巴斯福股份公司 | Granulates containing feed-enzymes |
US7501269B2 (en) | 2002-01-15 | 2009-03-10 | Basf Aktiengesellschaft | Granulates containing feed-enzymes |
WO2003059087A1 (en) * | 2002-01-15 | 2003-07-24 | Basf Ag | Granulates containing feed-enzymes |
US7611877B2 (en) | 2002-01-15 | 2009-11-03 | Basf Aktiengesellschaft | Granulates containing feed-enzymes |
US7736680B2 (en) | 2002-09-13 | 2010-06-15 | Cornell Research Foundation, Inc. | Using mutations to improve Aspergillus phytases |
US20150024081A1 (en) * | 2004-09-27 | 2015-01-22 | Novozymes A/S | Enzyme Granules |
WO2006034710A1 (en) * | 2004-09-27 | 2006-04-06 | Novozymes A/S | Enzyme granules |
US20210186058A1 (en) * | 2004-09-27 | 2021-06-24 | Novozymes A/S | Enzyme Granules |
EP2163161A1 (en) * | 2004-09-27 | 2010-03-17 | Novozymes A/S | Enzyme Granules |
EP2160950A1 (en) * | 2004-09-27 | 2010-03-10 | Novozymes A/S | Enzyme granules |
EP2258209A1 (en) * | 2004-09-27 | 2010-12-08 | Novozymes A/S | Enzyme Granules |
US20160205971A1 (en) * | 2004-09-27 | 2016-07-21 | Novozymes A/S | Enzyme Granules |
EP2143338A1 (en) * | 2004-09-27 | 2010-01-13 | Novozymes A/S | Enzyme Granules |
US20120093976A1 (en) * | 2004-09-27 | 2012-04-19 | Novozymes A/S | Enzyme Granules |
EP2143339A1 (en) * | 2004-09-27 | 2010-01-13 | Novozymes A/S | Enzyme Granules |
AU2017202595B2 (en) * | 2005-10-12 | 2018-11-22 | Genencor International, Inc. | Stable, durable granules with active agents |
EP2497376A3 (en) * | 2005-10-12 | 2013-01-02 | Danisco US Inc. | Stable, durable granules with active agents |
EP2497378A3 (en) * | 2005-10-12 | 2013-09-04 | Danisco US Inc. | Stable, durable granules with active agents |
US7803413B2 (en) | 2005-10-31 | 2010-09-28 | General Mills Ip Holdings Ii, Llc. | Encapsulation of readily oxidizable components |
US7803414B2 (en) | 2005-10-31 | 2010-09-28 | General Mills Ip Holdings Ii, Llc | Encapsulation of readily oxidizable components |
US8142831B2 (en) | 2005-10-31 | 2012-03-27 | General Mills Ip Holdings Ii, Llc | Encapsulation of readily oxidizable components |
EP1974030B1 (en) | 2006-01-17 | 2016-09-14 | AB Enzymes GmbH | Improved enzyme formulations for animal feed |
US7919297B2 (en) | 2006-02-21 | 2011-04-05 | Cornell Research Foundation, Inc. | Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase |
US8540984B2 (en) | 2006-08-03 | 2013-09-24 | Cornell Research Foundation, Inc. | Phytases with improved thermal stability |
WO2012110777A2 (en) | 2011-02-18 | 2012-08-23 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US10695384B2 (en) | 2011-02-18 | 2020-06-30 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US11172693B2 (en) | 2011-02-18 | 2021-11-16 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2012110776A2 (en) | 2011-02-18 | 2012-08-23 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2012110778A2 (en) | 2011-02-18 | 2012-08-23 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US10829721B2 (en) | 2011-06-20 | 2020-11-10 | Novozymes A/S | Particulate composition |
WO2013003025A1 (en) | 2011-06-20 | 2013-01-03 | The Procter & Gamble Company | Consumer products with lipase comprising coated particles |
WO2012175401A2 (en) | 2011-06-20 | 2012-12-27 | Novozymes A/S | Particulate composition |
EP2537918A1 (en) | 2011-06-20 | 2012-12-26 | The Procter & Gamble Company | Consumer products with lipase comprising coated particles |
WO2014020138A2 (en) * | 2012-08-03 | 2014-02-06 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2014020138A3 (en) * | 2012-08-03 | 2014-03-27 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US9179693B2 (en) | 2012-08-03 | 2015-11-10 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US10149891B2 (en) | 2012-08-03 | 2018-12-11 | Dupont Nutrition Biosciences Aps | Feed additive composition |
US11235035B2 (en) | 2012-08-03 | 2022-02-01 | Dupont Nutrition Biosciences Aps | Feed additive composition |
WO2014191170A1 (en) | 2013-05-30 | 2014-12-04 | Novozymes A/S | Particulate enzyme composition |
US11981942B2 (en) | 2013-07-23 | 2024-05-14 | International N&H Denmark Aps | Xylanases for solubilizing arabinoxylan-containing material |
US10463701B2 (en) | 2013-12-31 | 2019-11-05 | DuPont Nutrition BioScience ApS | Blends of Bacillus strains and enzymes |
EP3702450A1 (en) | 2014-01-31 | 2020-09-02 | DuPont Nutrition Biosciences ApS | Protein |
WO2015116395A1 (en) | 2014-01-31 | 2015-08-06 | Danisco Us Inc. | Methods for improving by-products from fermentation processes using xylanase |
WO2015114112A1 (en) | 2014-01-31 | 2015-08-06 | Dupont Nutrition Biosciences Aps | Protein |
WO2017040499A1 (en) | 2015-09-02 | 2017-03-09 | Dupont Nutrition Biosciences Aps | Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal |
EP3711773A1 (en) | 2015-09-02 | 2020-09-23 | DuPont Nutrition Biosciences ApS | Glycoside hydrolases and their use in preventing and/or treating a pathogenic infection in an animal |
EP3825399A1 (en) | 2016-06-30 | 2021-05-26 | Danisco US Inc. | Aspartic proteases |
WO2018005225A1 (en) | 2016-06-30 | 2018-01-04 | Danisco Us Inc | Aspartic proteases |
WO2018057420A1 (en) | 2016-09-23 | 2018-03-29 | Dupont Nutrition Biosciences Aps | Use of low ph active alpha-1,4/1,6-glycoside hydrolases as a feed additive for ruminants to enhance starch digestion |
WO2018118815A1 (en) | 2016-12-21 | 2018-06-28 | Dupont Nutrition Biosciences Aps | Methods of using thermostable serine proteases |
WO2018164876A1 (en) | 2017-03-06 | 2018-09-13 | Dupont Nutrition Biosciences Aps | Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal |
WO2018169750A1 (en) | 2017-03-15 | 2018-09-20 | Danisco Us Inc | Trypsin-like serine proteases and uses thereof |
WO2018169784A1 (en) | 2017-03-15 | 2018-09-20 | Dupont Nutrition Biosciences Aps | Trypsin-like serine proteases and uses thereof cross-reference to related application |
US11525151B2 (en) | 2018-03-09 | 2022-12-13 | Danisco Us Inc. | Glucoamylases and methods of use, thereof |
WO2019173424A1 (en) | 2018-03-09 | 2019-09-12 | Danisco Us Inc | Glucoamylases and methods of use thereof |
WO2020106796A1 (en) | 2018-11-20 | 2020-05-28 | Dupont Nutrition Biosciences Aps | ENGINEERED ROBUST HIGH Tm-PHYTASE CLADE POLYPEPTIDES AND FRAGMENTS THEREOF |
WO2021007379A1 (en) | 2019-07-09 | 2021-01-14 | Dupont Nutrition Biosciences Aps | Fat coated particulate enzyme compositions |
WO2021034660A1 (en) | 2019-08-16 | 2021-02-25 | Dupont Nutrition Biosciences Aps | Compositions for gut health comprising combinations of lactobacillus strains |
WO2021046073A1 (en) | 2019-09-05 | 2021-03-11 | Dupont Nutrition Biosciences Aps | Feed composition |
WO2021080864A2 (en) | 2019-10-21 | 2021-04-29 | Dupont Nutrition Biosciences Aps | Compositions for gut health |
WO2021102238A1 (en) | 2019-11-20 | 2021-05-27 | Dupont Nutrition Biosciences Aps | Thermostable phytase variants |
CN110846303A (en) * | 2019-11-23 | 2020-02-28 | 吉林省富生医疗器械有限公司 | Peroxidase protective agent |
WO2021127360A1 (en) | 2019-12-19 | 2021-06-24 | Dupont Nutrition Biosciences Aps | Diet formulations |
WO2021158927A1 (en) | 2020-02-07 | 2021-08-12 | Dupont Nutrition Biosciences Aps | Feed compositions for animal health |
WO2021173974A1 (en) | 2020-02-28 | 2021-09-02 | Dupont Nutrition Biosciences Aps | Feed compositions |
WO2021212095A1 (en) | 2020-04-17 | 2021-10-21 | Danisco Us Inc. | Glucoamylase and methods of use thereof |
WO2022081947A1 (en) | 2020-10-16 | 2022-04-21 | Dupont Nutrition Biosciences | Feed compositions for animal health |
WO2022169933A2 (en) | 2021-02-03 | 2022-08-11 | Dupont Nutrition Biosciences Aps | Compositions for gut health |
WO2023049488A1 (en) | 2021-09-27 | 2023-03-30 | Dupont Nutrition Biosciences Aps | Feed additive compositions and methods for using the same |
WO2023064905A1 (en) | 2021-10-15 | 2023-04-20 | Danisco Us Inc. | Glucoamylase variants and methods for use thereof |
WO2023122676A1 (en) | 2021-12-24 | 2023-06-29 | Danisco Us Inc. | Hybrid glucoamylases and methods of use thereof |
WO2023225510A1 (en) | 2022-05-17 | 2023-11-23 | Dupont Nutrition Biosciences Aps | Feed additive comprising enzyme combinations |
WO2024064653A1 (en) | 2022-09-20 | 2024-03-28 | Dupont Nutrition Biosciences Aps | Variant anti-viral polypeptides |
WO2024124013A1 (en) | 2022-12-09 | 2024-06-13 | International N&H Denmark Aps | Feed formulations comprising a phytase for dairy ruminant animals |
Also Published As
Publication number | Publication date |
---|---|
JPH11514240A (en) | 1999-12-07 |
EP0858266A1 (en) | 1998-08-19 |
AU7489896A (en) | 1997-05-22 |
CN1201372A (en) | 1998-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997016076A1 (en) | Feed enzyme preparations | |
EP1117771B1 (en) | Solid phytase compositions | |
US11229223B2 (en) | Enzyme granules for animal feed | |
US8846361B2 (en) | Solid phytase compositions stabilized with corn steep liquor | |
JP4515094B2 (en) | Enzyme-containing granules for feed | |
EP2051590B1 (en) | Enzyme granules for animal feed | |
CN102742732B (en) | Solid enzyme formulations and preparation method thereof | |
US20090274795A1 (en) | Enzyme Granulate l Containing Phytase | |
CN101291592A (en) | Phytase-containing enzyme granulate ii | |
EP0257996B1 (en) | Feed premix and production method therefor | |
JP2002536005A (en) | Granules containing feed enzymes | |
KR20040075076A (en) | Granulates containing feed-enzymes | |
CA2667976A1 (en) | Protein-containing agent with increased thermal stability | |
EP3890507A1 (en) | Use of an enzyme granule | |
CN107129980A (en) | A kind of feed protein enzyme preparation preserves carrier and preparation method and application | |
AU2003202563B2 (en) | Granulates containing feed-enzymes | |
CN107709572A (en) | Promote to extract the method for enzyme and the assay method of enzymatic activity from animal feed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96197980.1 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996937191 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1997 516999 Country of ref document: JP Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1996937191 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996937191 Country of ref document: EP |